ArticlePharmacological research2024

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.

Silpa Gampala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.